The interferon-inducible HIN-200 gene family in apoptosis and inflammation: Implication for autoimmunity

References

• Ludlow LE, Johnstone RW, Clarke CJ. The HIN-200 family: More than interferon-inducible genes?. Exp Cell Res. 2005; 308:1–17.
   PubMedGoogle Scholar
• Asefa B, Klarmann KD, Copeland NG, Gilbert DJ, Jenkins NA, Keller JR. The interferon-inducible p200 family of proteins: A perspective on their roles in cell cycle regulation and differentiation. Blood Cells Mol Dis. 2004; 32:155–167.
   PubMed Web of Science ®Google Scholar
• Albrecht M, Choubey D, Lengauer T. The HIN domain of IFI-200 proteins consists of two OB folds. Biochem Biophys Res Commun. 2005; 327:679–687.
   PubMedGoogle Scholar
• Yan H, Dalal K, Hon BK, Youkharibache P, Lau D, Pio F. RPA nucleic acid-binding properties of IFI16-HIN200. Biochim Biophys Acta. 2008; 1784:1087–1097.
   PubMedGoogle Scholar
• Martinon F, Hofmann K, Tschopp J. The pyrin domain: A possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr Biol. 2001; 11:R118–R120.
   Google Scholar
• Taniguchi S, Sagara J. Regulatory molecules involved in inflammasome formation with special reference to a key mediator protein, ASC. Semin Immunopathol. 2007; 29:231–238.
   PubMed Web of Science ®Google Scholar
• Crow MK. Type I interferon in systemic lupus erythematosus. Curr Top Microbiol Immunol. 2007; 316:359–386.
   PubMed Web of Science ®Google Scholar
• Coelho LF, de Oliveira JG, Kroon EG. Interferons and scleroderma—a new clue to understanding the pathogenesis of scleroderma?. Immunol Lett. 2008; 118:110–115.
   PubMed Web of Science ®Google Scholar
• Nordmark G, Alm GV, Ronnblom L. Mechanisms of disease: Primary Sjogren's syndrome and the type I interferon system. Nat Clin Pract Rheumatol. 2006; 2:262–269.
   PubMedGoogle Scholar
• Zandman-Goddard G, Blank M. Apoptosis and autoimmunity. Isr Med Assoc J. 2002; 4:722–724.
   Google Scholar
• Briggs RC, Shults KE, Flye LA, McClintock-Treep SA, Jagasia MH, Goodman SA, Boulos FI, Jacobberger JW, Stelzer GT, Head DR. Dysregulated human myeloid nuclear differentiation antigen expression in myelodysplastic syndromes: Evidence for a role in apoptosis. Cancer Res. 2006; 66:4645–4651.
   PubMed Web of Science ®Google Scholar
• Choubey D, Panchanathan R. Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol Lett. 2008; 119:32–41.
   PubMed Web of Science ®Google Scholar
• Chen IF, Ou-Yang F, Hung JY, Liu JC, Wang H, Wang SC, Hou MF, Hortobagyi GN, Hung MC. AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model. Mol Cancer Ther. 2006; 5:1–7.
   Google Scholar
• Burckstummer T, Baumann C, Bluml S, Dixit E, Durnberger G, Jahn H, Planyavsky M, Bilban M, Colinge J, Bennett KL, Superti-Furga G. An orthogonal proteomic–genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol. 2009; 10:266–272.
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature. 2009; 458:509–513.
   PubMed Web of Science ®Google Scholar
• Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, Fitzgerald KA. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature. 2009; 458:514–518.
   PubMed Web of Science ®Google Scholar
• Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, Hodgson S, Hardy LL, Garceau V, Sweet MJ, Ross IL, Hume DA, Stacey KJ. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science. 2009; 323:1057–1060.
   PubMed Web of Science ®Google Scholar
• Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: Host cell death and inflammation. Nat Rev Microbiol. 2009; 7:99–109.
   PubMed Web of Science ®Google Scholar
• Aglipay JA, Lee SW, Okada S, Fujiuchi N, Ohtsuka T, Kwak JC, Wang Y, Johnstone RW, Deng C, Qin J, Ouchi T. A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway. Oncogene. 2003; 22:8931–8938.
   PubMedGoogle Scholar
• Fujiuchi N, Aglipay JA, Ohtsuka T, Maehara N, Sahin F, Su GH, Lee SW, Ouchi T. Requirement of IFI16 for the maximal activation of p53 induced by ionizing radiation. J Biol Chem. 2004; 279:20339–20344.
   PubMedGoogle Scholar
• Caposio P, Gugliesi F, Zannetti C, Sponza S, Mondini M, Medico E, Hiscott J, Young HA, Gribaudo G, Gariglio M, Landolfo S. A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells. J Biol Chem. 2007; 282:33515–33529.
   PubMedGoogle Scholar
• Chadwick N, Fennessy C, Nostro MC, Baron M, Brady G, Buckle AM. Notch induces cell cycle arrest and apoptosis in human erythroleukaemic TF-1 cells. Blood Cells Mol Dis. 2008; 41:270–277.
   Google Scholar
• Ding Y, Wang L, Su LK, Frey JA, Shao R, Hunt KK, Yan DH. Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer. Oncogene. 2004; 23:4556–4566.
   PubMed Web of Science ®Google Scholar
• Ding Y, Lee JF, Lu H, Lee MH, Yan DH. Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2. Mol Cell Biol. 2006; 26:1979–1996.
   PubMedGoogle Scholar
• Schett G. Review: Immune cells and mediators of inflammatory arthritis. Autoimmunity. 2008; 41:224–229.
   PubMed Web of Science ®Google Scholar
• Miranda RN, Briggs RC, Shults K, Kinney MC, Jensen RA, Cousar JB. Immunocytochemical analysis of MNDA in tissue sections and sorted normal bone marrow cells documents expression only in maturing normal and neoplastic myelomonocytic cells and a subset of normal and neoplastic B lymphocytes. Hum Pathol. 1999; 30:1040–1049.
   PubMed Web of Science ®Google Scholar
• Schroder K, Muruve DA, Tschopp J. Innate immunity: Cytoplasmic DNA sensing by the AIM2 inflammasome. Curr Biol. 2009; 19:R262–R265.
   PubMed Web of Science ®Google Scholar
• Raffaella R, Gioia D, De Andrea M, Cappello P, Giovarelli M, Marconi P, Manservigi R, Gariglio M, Landolfo S. The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells. Exp Cell Res. 2004; 293:331–345.
   PubMedGoogle Scholar
• Gariglio M, Azzimonti B, Pagano M, Palestro G, De Andrea M, Valente G, Voglino G, Navino L, Landolfo S. Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. J Interferon Cytokine Res. 2002; 22:815–821.
   PubMedGoogle Scholar
• Wei W, Clarke CJ, Somers GR, Cresswell KS, Loveland KA, Trapani JA, Johnstone RW. Expression of IFI 16 in epithelial cells and lymphoid tissues. Histochem Cell Biol. 2003; 119:45–54.
   PubMedGoogle Scholar
• Gugliesi F, Mondini M, Ravera R, Robotti A, de Andrea M, Gribaudo G, Gariglio M, Landolfo S. Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells. J Leukoc Biol. 2005; 77:820–829.
   Google Scholar
• Mondini M, Vidali M, Airo P, De Andrea M, Riboldi P, Meroni PL, Gariglio M, Landolfo S. Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders. Ann N Y Acad Sci. 2007; 1110:47–56.
   PubMedGoogle Scholar
• Sponza S, De Andrea M, Mondini M, Gugliesi F, Gariglio M, Landolfo S. Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF-alpha. Cell Immunol. 2009; 257:55–60.
   Google Scholar
• Rozzo SJ, Allard JD, Choubey D, Vyse TJ, Izui S, Peltz G, Kotzin BL. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity. 2001; 15:435–443.
   PubMed Web of Science ®Google Scholar
• Mondini M, Vidali M, De Andrea M, Azzimonti B, Airo P, D'Ambrosio R, Riboldi P, Meroni PL, Albano E, Shoenfeld Y, Gariglio M, Landolfo S. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: The interferon-inducible gene IFI16. Arthritis Rheum. 2006; 54:3939–3944.
   PubMed Web of Science ®Google Scholar
• Hueber W, Zeng D, Strober S, Utz PJ. Interferon-alpha-inducible proteins are novel autoantigens in murine lupus. Arthritis Rheum. 2004; 50:3239–3249.
   PubMedGoogle Scholar
• Maniati E, Potter P, Rogers NJ, Morley BJ. Control of apoptosis in autoimmunity. J Pathol. 2008; 214:190–198.
   Google Scholar
• Navratil JS, Liu CC, Ahearn JM. Apoptosis and autoimmunity. Immunol Res. 2006; 36:3–12.
   PubMed Web of Science ®Google Scholar
• Schultz DR, Harrington WJJr. Apoptosis: Programmed cell death at a molecular level. Semin Arthritis Rheum. 2003; 32:345–369.
   PubMed Web of Science ®Google Scholar
• Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus. 1998; 7:113–118.
   PubMed Web of Science ®Google Scholar
• Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev. 2005; 4:189–194.
   PubMed Web of Science ®Google Scholar
• Gatzka M, Walsh CM. Apoptotic signal transduction and T cell tolerance. Autoimmunity. 2007; 40:442–452.
   PubMed Web of Science ®Google Scholar
• Tincani A, Andreoli L, Bazzani C, Bosiso D, Sozzani S. Inflammatory molecules: A target for treatment of systemic autoimmune diseases. Autoimmun Rev. 2007; 7:1–7.
   PubMedGoogle Scholar